Prerequisites to Implementing a Pharmacogenomics Program in a Large Health‐Care System | Zendy

Levy K D | Zendy; Decker B S | Zendy; Carpenter J S | Zendy; Flockhart D A | Zendy; Dexter P R | Zendy; Desta Z | Zendy; Skaar T C | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Prerequisites to Implementing a Pharmacogenomics Program in a Large Health‐Care System

Author(s) -

Levy K D,

Decker B S,

Carpenter J S,

Flockhart D A,

Dexter P R,

Desta Z,

Skaar T C

Publication year - 2014

Publication title -

clinical pharmacology and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.941

H-Index - 188

eISSN - 1532-6535

pISSN - 0009-9236

DOI - 10.1038/clpt.2014.101

Subject(s) - pharmacogenomics , clinical pharmacology , personalized medicine , lagging , health care , key (lock) , medicine , medical education , computer science , pharmacology , bioinformatics , political science , biology , computer security , pathology , law

Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be delivered in order to ensure a successful and enduring PGx implementation within a large health‐care system. Clinical Pharmacology & Therapeutics (2014); 96 3, 307–309. advance online publication 11 June 2014. doi: 10.1038/clpt.2014.101

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research